This listing has expired.
Recent Posts
- Imagion Biosystems Delivers Major Milestone — IND Application Lodged with U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent
- Quarterly Activities Report and Appendix 4C – December 2025
- Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
- The Market Bull Podcast – Imagion Biosystems and the Future of MRI
- Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection
Categories
- News (272)
- Investor updates (392)
- Scientific Publications (10)
- Press & Media (23)
- Events & Webinars (27)
- Company Update (32)
- Newsletters (9)